<DOC>
	<DOCNO>NCT00433823</DOCNO>
	<brief_summary>Cholesterol precursor glucocorticoid , mineralocorticoid sex steroid . Both adrenal non-adrenal ( ovarian + testicular ) steroid hormone primarily synthesize use LDL–cholesterol circulation . Additionally ‘ de novo ’ cholesterol synthesis adrenal gonad control HMG-CoA reductase enzyme . A third pathway use circulatory HDL–cholesterol adrenal gonadal tissue synthesis steroid . Since statin decrease circulatory LDL inhibit de novo cholesterol synthesis , likely affect synthesis steroid hormone . In study aim investigate effect lower LDL level 70 mg/dL steroid hormone synthesis .</brief_summary>
	<brief_title>A Study Evaluating Effects Lipid Lowering Treatment Steroid Synthesis</brief_title>
	<detailed_description>Today atherosclerotic disease among important cause death world . Epidemiological , clinical , genetic , experimental pathological study clearly show role lipoproteins atherosclerosis . LDL major atherogenic lipoprotein define primary target lipid lower treatment NCEP . Although level LDL , primary target treatment dyslipidemia , set 100mg/dl coronary heart disease ( CHD ) CHD risk equivalent , level pull 70mg/dl group define high risk group ATP ( Adult Treatment Panel ) guide update follow new clinical study . As already know , cholesterol precursor glucocorticoid , mineralocorticoid sex steroid , besides structural component cell membrane . Both adrenal non-adrenal ( ovarian+testicular ) steroid hormone primarily synthesize use LDL-cholesterol circulation . In addition , 'de novo ' cholesterol synthesis adrenal gonad control HMG-CoA reductase enzyme . A third pathway , normal circumstance little contribution compare first two , use circulatory HDL-cholesterol adrenal gonadal tissue synthesis steroid . Our knowledge extremely lower LDL level quite limit . However , since statin decrease circulatory LDL inhibit de novo cholesterol synthesis , likely affect synthesis steroid hormone .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>Patients high risk group accord ATPIII guide . Patients major disease involve hepatic , gastrointestinal endocrinologic disease diabetes . Patients know muscle disease Pregnancy , breastfeed Patients history allergy statin ezetimibe Nephropathic patient</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2007</verification_date>
	<keyword>Very low level LDL</keyword>
	<keyword>Steroid hormone</keyword>
	<keyword>Atorvastatin</keyword>
	<keyword>Ezetimibe</keyword>
	<keyword>Lipoprotein-a</keyword>
</DOC>